| Trial name or title |
"The Efficacy of Intranasal Budesonide and Leukotriene Modifier Therapy for Mild‐moderate Pediatric Obstructive Sleep Apnea Hypopnea Syndrome" |
| Methods |
Parallel group randomised trial |
| Participants |
75 children (planned), age 2 to 14 years, with mild to moderate OSA |
| Interventions |
3 groups: montelukast orally, budesonide intranasally, and a combination of both |
| Outcomes |
"urine LTE4 level, overnight PSG parameters, A/N ratio, OSA questionnaire scores" |
| Starting date |
January 2012 |
| Contact information |
Dr. Aihuan Chen (chaih163@163.com) |
| Notes |
Funding sources: Principal Investigator Funds |
